临沧哪做宫颈糜烂好-【临沧云洲医院】,临沧云洲医院,临沧输卵管通水医院哪家好,临沧不孕治疗方法,临沧女性外阴晚上瘙痒,临沧尿常规检查细菌高,临沧早孕b超检查的妇科医院,临沧阴道里面有个小肉芽
临沧哪做宫颈糜烂好临沧最近阴道出血,临沧尿道感染怎么医治,临沧阴唇有点痒,临沧月经血量少怎么办,临沧做妇科检查,临沧阴部出血是为什么,临沧月经每隔一个月来一次
Google chairman Eric Schmidt has promised that the firm will simplify the process by which Android phone users agree to share their data.It follows questions in the US Senate about how much location information is stored by mobile handsets.Speaking in the UK at a conference on privacy, he also revealed that Google plans to offer web users more control over their online profile.Mr Schmidt insisted that the company took the matter "very seriously".He told attendees at the Big Tent debate in Hertfordshire that his firm was working on "a series of projects" aimed at increasing transparency.Those include a revised Google Dashboard, where users can see what data they have shared with the search giant."It is worth stressing that we can only do this with data you have shared with Google. We can't be a vacuum-cleaner for the whole internet," he said.Mr Schmidt stressed that Google was on the side of consumers when it came to privacy. "In general we take the position that you own your data and should be able to opt in or out of a service," he said.But he added that if users gave consent for sharing data, it would help Google improve its services."If you choose to give us that information we can do a better job. If we know a little bit more about you we can offer better targeted search," he explained.Super injunctions revealed A recent hearing in the US Senate quizzed Google on the amount of data stored on Android handsets. The company argued that it allows people to opt out of location-based services.But Mr Schmidt conceded that the terms and conditions whereby users sign up to services needs to be simplified. "We intent to do that," he said.He predicted that such services would be more heavily regulated in the future.During a lively debate on the issue of privacy, it was revealed to the Big Tent audience, alongside several names of current super-injunction holders, that more data has been collected in the last seven years than in the whole of previous human history.
WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.
GUIYANG, Jan. 23 (Xinhua) -- Migrant workers, or off-farm workers, in China should enjoy paid annual family-visit vacations as their urban counterparts, a political advisor in southwest China's Guizhou Province had said."Localities could legislate on the issue on a trail basis," said Yu Peixuan, a member of the Guizhou Provincial Committee of the Chinese People's Political Consultative Conference (CPPCC), made this proposal at the political advisory body's annual session held Jan. 16-22.If migrant workers took paid home leave every year, they would have more time to help their wives in rural homes do the heavy farm work and educate their children, said Yu. "Thus, family ties would be cemented."Statistics show that 47 million women remain at home in rural China when adult males go off to cities to earn their livings.These women played an important role in taking care of the elderly people and children in their rural homes, but they also face many practical difficulties, such as heavy farm work and dull daily life.One of the major factors affecting these women's quality of life was the lack of communications with their husbands, said Yu.Yu called on large enterprises to allow migrant workers to take paid home leave first to set an example for other enterprises.According to the present Labour Law, regular workers at government organs, institutions and state-owned enterprises are eligible for paid vacations of one month per year to visit separated spouses in different cities or regions.
SAN FRANCISCO, March 21 (Xinhua) -- Microsoft on Monday sued Barnes & Noble, claiming patent infringement by the largest book retailer in the United States.Microsoft said it filed legal actions on Monday in both the U.S. International Trade Commission and the U.S. District Court of the Western District of Washington against Barnes & Noble, as well as Foxconn and Inventec, two manufacturers of Barnes & Noble's devices.According to Microsoft, the actions focus on the patent infringement by Barnes & Noble's Nook e-reader and tablet, both of which run Google's Android operating system.The patents at issue cover a range of functionality embodied in Android devices that are essential to the user experience, including natural ways of interacting with devices by tabbing through various screens to find the information they need, surfing the Web more quickly and interacting with documents and e-books, Microsoft said in a press release."The Android platform infringes a number of Microsoft's patents, and companies manufacturing and shipping Android devices must respect our intellectual property rights," Horacio Gutierrez, Microsoft's corporate vice president and deputy general counsel, was quoted by the press release as saying.Writing in a separate company blog post, Gutierrez said that the latest actions bring to 25 the total number of Microsoft patents in litigation for infringement by Android smartphones, tablets and other devices.He noted that Microsoft has established a licensing program to address Android's ongoing infringement, and leading Android smartphone manufacturer HTC has taken a license under this program.Amazon.com also signed a patent license with Microsoft last year covering its Kindle e-reader, he added."Unfortunately, after more than a year of discussions, Barnes & Noble, Foxconn and Inventec have so far been unwilling to sign a license, and therefore, we have no other choice but to bring legal action to defend our innovations," Gutierrez said in the blog post.